Weici Wang

Weici Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KHKe Hu
Ke Hu
YLYiqing Li
Yiqing Li
YGYi Guo
Yi Guo
PCPeng Cheng
Peng Cheng
YLYuxuan Li
Yuxuan Li
WWWeici Wang
Weici Wang
(1) Background: Arteriovenous fistulas (AVFs) are the preferred access for hemodialysis. Unfortunately, about 60% of patients, especially female patients, fail to receive normal dialysis within one year after surgery because of AVF failure. However, the underlying mechanisms caused by sex differences in AVF failure remain unclear. (2) Methods: We performed analysis of DEGs and functional analysis with the dataset GSE119296 to reveal the biology underlying AVF failure. Immune responses were calculated using CIBERSORT. A protein–protein interaction network and hub gene were constructed using STRING and stepwise identification of potential drugs was performed online. (3) Results: Functional analysis showed that extracellular matrix reprogramming and PI3K-AKT pathway enrichment were significant in both male and female patients. COL1A1 was the hub gene in male patients, whereas CDK1 was the hub gene in female patients. Immune responses including γδ-T cells and mast cells are activated in female patients while no significant differences were noted in the male group. (4) Conclusions: In this study, we used a series of mature and recognized bioinformatic strategies to determine the following items: (1) Reveal the pathogenesis of AVF failure through HUB genes and signaling pathways between the different sexes. (2) Determine the relationship between sex differences in AVF failure and immune abnormalities. (3) Search for relevant sex-specific drugs targeting AVF failure.

18 January 2024 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
YLYuxuan Li
Yuxuan Li
KHKe Hu
Ke Hu
YLYiqing Li
Yiqing Li
CLChanjun Lu
Chanjun Lu
YGYi Guo
Yi Guo
WWWeici Wang
Weici Wang
Arteriovenous fistulas (AVFs) have long been used as dialysis access in patients with end-stage renal disease; however, their maturation and long-term patency still fall short of clinical needs. Rodent models are irreplaceable to facilitate the study of mechanisms and provide reliable insights into clinical problems. The ideal rodent AVF model recapitulates the major features and pathology of human disease as closely as possible, and pre-induction of the uremic milieu is an important addition to AVF failure studies. Herein, we review different surgical methods used so far to create AVF in rodents, including surgical suturing, needle puncture, and the cuff technique. We also summarize commonly used evaluations after AVF placement. The aim was to provide recent advances and ideas for better selection and induction of rodent AVF models. At the same time, further improvements in the models and a deeper understanding of AVF failure mechanisms are expected.

1 November 2023 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
KHKe Hu
Ke Hu
YGYi Guo
Yi Guo
YLYuxuan Li
Yuxuan Li
SZShunchang Zhou
Shunchang Zhou
YLYiqing Li
Yiqing Li
WWWeici Wang
Weici Wang
Background: Aortic dissection (AD) poses a great threat to the life of patients; however, there is currently no documentation of a clear pathogenic mechanism of this disease. In recent years, β-aminopropionitrile (BAPN)-induced AD in rodents has been widely used in basic research, which provides a good platform for exploring the pathogenesis of AD and drug modification. This study aimed to identify molecular markers and pathways for the diagnosis and treatment of AD by comparing a murine AD model and human AD transcriptome through a bioinformatics analysis. Methods: We constructed a BAPN-induced mice model and performed high-throughput sequencing analysis. The GSE147026 dataset of patients was obtained from the Gene Expression Omnibus database. We performed a subsequent bioinformatics analysis of human AD and the murine AD model using R software. The DESeq software package was used to analyze the differentially expressed genes (DEGs). Gene ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to analyze the enrichment pathways. Protein-protein interaction network construction and hub gene selection were based on STRING software analysis. Stepwise identification of potential drugs was performed online, while hub genes were validated immunohistochemically. Results: We compared the murine AD model and human AD transcriptome and found that both differentially expressed 463 genes. The cytokine-cytokine receptor interaction, tuberculosis, and phagosome pathways were significantly enriched. CDC20, CCNB2, and CCNB1 may be associated with AD development. Protein-drug interactions were also identified. Conclusions: This study is the first to reveal transcriptional changes in a murine BAPN-induced AD model versus human AD transcriptome. Furthermore, we identified the important hub genes, related pathways, and potential drugs by analyzing the overlapping DEGs between human AD and the murine AD model. Our results provide a basis for the further identification of potential molecular markers for diagnosing and treating AD.

1 November 2024 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
LWLulu Wang
Lulu Wang
CYCheng Yu
Cheng Yu
KHKe Hu
Ke Hu
YGYi Guo
Yi Guo
YLYuxuan Li
Yuxuan Li
WWWeici Wang
Weici Wang
Acute pulmonary embolism (APE) has a high mortality rate worldwide. The cause of death from pulmonary embolism (PE) is predominantly progressive right heart failure, which is common in intermediate-high-risk and high-risk patients. The latest guidelines recommend reperfusion thrombolytic therapy for high-risk patients, but it is rarely practiced clinically, given the high rate of intracranial hemorrhage. Moreover, the optimal treatment for intermediate-risk patients remains undetermined. With the development of technology, a series of endovascular interventional treatments are widely used in patients with intermediate-high-risk or high-risk PE, such as standard catheter-directed thrombolysis (SCDT), ultrasound-assisted thrombolysis (USAT), pharmacomechanical catheter-directed thrombolysis (PM-CDT) and mechanical thrombectomy (MT). Current studies have shown that interventional therapy can effectively improve right heart function and reduce the incidence of cerebral hemorrhage. Future research should mainly focus on screening patients who benefit from interventional therapy, reducing mortality, and improving long-term sequelae. This article aimed to review these treatment devices and provide an update on the research progress related to interventional therapy for PE. In addition, we introduce a risk stratification assessment for APE in the updated guidelines and provide an overview of risk indicators and APE scores for judging prognosis. Finally, we discuss the long-term outcomes of APE in combination with interventional therapy.

23 June 2025 in International Journal of Molecular Medicine
Verified
Journal Article
Closed access
KHKe Hu
Ke Hu
SBShichen Bu
Shichen Bu
YGYi Guo
Yi Guo
YLYuxuan Li
Yuxuan Li
SYShiwen Yu
Shiwen Yu
WWWeici Wang
Weici Wang
Arteriovenous fistulas (AVFs) are preferred access points for hemodialysis. The present study aimed to investigate the function of early growth response‑1 (Egr‑1) in the proliferation and migration of smooth muscle cells (SMCs) and assess its potential as a new therapeutic target for AVF treatment. A comprehensive analysis combining public data‑source mining, human tissue collection, animal studies, cell culture experiments and various molecular biology techniques was conducted. The public dataset GSE119296 was used for immunohistochemical analyses of human AVF stenosis samples. SMC‑specific Egr‑1 knockout mice and various in vitro assays on primary rat vascular SMCs were used to evaluate the effect of Egr‑1 on the functional capacity of SMCs. RNA sequencing and chromatin immunoprecipitation sequencing was performed. Egr‑1 was upregulated in human AVF stenosis samples and cultured SMCs. Knockout of Egr‑1 in mice mitigated AVF outflow tract stenosis, improved flow dynamics and diminished neointima formation. In vitro, Egr‑1 ablation reduced SMC proliferation and migration; Egr‑1 transcriptionally activated Egr‑2. Increased Egr‑1 expression facilitated SMC proliferation and migration through Egr‑2 regulation, contributing to AVF stenosis. Consequently, targeting Egr‑1 may offer a novel therapeutic approach for managing AVF intimal hyperplasia and improving AVF patency and function in patients with end‑stage renal disease.

20 May 2026 in Acta Biomaterialia
Verified
Journal Article
Open access
LGLinlin Guo
Linlin Guo
QHQi Huang
Qi Huang
CXChao Xu
Chao Xu
XDXianzhen Dong
Xianzhen Dong
YTYuyi Tian
Yuyi Tian
YLYiqing Li
Yiqing Li
Conventional hydrogel-based vascular grafts often fail because they lack mechanical strength, and their dense structure restricts cell infiltration. To overcome these challenges, we fabricated a bilayer fabric-reinforced composite vascular graft that integrates favorable mechanical properties with biological activity. The inner layer is composed of a hydrogel matrix mixed with vascular acellular matrix (VAM) particles and sacrificial gelatin microspheres, forming an interconnected biomimetic microchannel network that serves as a "cellular highway" to guide and enhance cell migration and tissue regeneration. The outer knitted polylactic acid (PLA) mesh provides substantial mechanical strength and improves suture retention, thereby overcoming the inherent mechanical limitations of hydrogels. After implantation in a rabbit carotid artery model for 3 months, the graft remodeled into a three-layered structure resembling native vessels, demonstrating 100% patency and an effective combination of mechanical strength and biological functionality. This approach addresses key limitations of conventional hydrogel-based vascular grafts and offers a promising strategy for the development of small-diameter vascular grafts. STATEMENT OF SIGNIFICANCE: Conventional hydrogel vascular grafts are plagued by poor mechanical strength and restricted cell infiltration. We engineered a bilayer fabric-reinforced graft: its inner hydrogel-VAM matrix, embedded with sacrificial gelatin microspheres, forms interconnected microchannels as a "cellular highway" for cell migration; the outer knitted PLA mesh enhances mechanical strength and suture retention. Rabbit carotid implantation achieved 100% patency and native vessel-like three-layer remodeling at 3 months. This scalable strategy resolves the mechanical-biological trade-off, advancing vascular tissue engineering and appealing to readers focused on biomaterial clinical translation.